Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.
复制标题
DOI:
10.1038/ng.2558
复制
发表时间:
2013-03
期刊:
影响因子:
30.8
通讯作者:
Carroll, William L.
中科院分区:
文献类型:
--
作者:
Meyer, Julia A.;Wang, Jinhua;Hogan, Laura E.;Yang, Jun J.;Dandekar, Smita;Patel, Jay P.;Tang, Zuojian;Zumbo, Paul;Li, Sheng;Zavadil, Jiri;Levine, Ross L.;Cardozo, Timothy;Hunger, Stephen P.;Raetz, Elizabeth A.;Evans, William E.;Morrison, Debra J.;Mason, Christopher E.;Carroll, William L.
Relapsed childhood acute lymphoblastic leukemia (ALL) carries a poor prognosis despite intensive retreatment, due to intrinsic drug resistance. The biological pathways that mediate resistance are unknown. Here we report the transcriptome profiles of matched diagnosis and relapse bone marrow specimens from ten pediatric B lymphoblastic leukemia patients using RNA-sequencing. Transcriptome sequencing identified 20 newly acquired novel non-synonymous mutations not present at initial diagnosis, of which two patients harbored relapse specific mutations in the same gene, NT5C2, a 5′-nucleotidase. Full exon sequencing of NT5C2 was completed in 61 additional relapse specimens, identifying five additional cases. Enzymatic analysis of mutant proteins revealed that base substitutions conferred increased enzymatic activity and resistance to treatment with nucleoside analogue therapies. Clinically, all patients who harbored NT5C2 mutations relapsed early, or within 36 months of initial diagnosis (p=0.03). These results suggest that mutations in NT5C2 are associated with the outgrowth of drug resistant clones in ALL.
登录
查看更多内容
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
20.3
作者:
Eapen, M;Raetz, E;Davies, SM
通讯作者:
Davies, SM
影响因子:
5.8
作者:
Jordheim, Lars Petter;Marton, Zsuzsanna;Chaloin, Laurent
通讯作者:
Chaloin, Laurent
DOI:
10.1046/j.1432-1327.1999.00099.x
发表时间:
1999-02-01
期刊:
EUROPEAN JOURNAL OF BIOCHEMISTRY
影响因子:
--
作者:
Spychala, J;Chen, V;Mitchell, BS
通讯作者:
Mitchell, BS